Page 2 - SAMRC Annual Report 2024-2025

CONTENTS

PART A PART B
GENERAL INFORMATION PERFORMANCE INFORMATION

SAMRC’S GENERAL AUDITOR’S REPORT: PROGRAMME 3: HIV, AIDS,
INFORMATION 2 PREDETERMINED OBJECTIVES 27 TB AND OTHER COMMUNICABLE
DISEASES 78
LIST OF ABBREVIATIONS/ OVERVIEW OF PERFORMANCE 28
ACRONYMS 3 PROGRAMME 4: HEALTH
Service Delivery Environment 28
SYSTEMS STRENGTHENING 106
FOREWORD BY THE Organisational environment 28
CHAIRPERSON 4 Key policy developments and PROGRAMME 5: PUBLIC
legislative changes 28 HEALTH INNOVATION 120
A NOTE FROM
THE PRESIDENT AND CEO 6 Progress towards achievement PROGRAMME 6:
of institutional Impacts and BIOMEDICAL RESEARCH 138
ACHIEVEMENTS AND Outcomes 28
HIGHLIGHTS 8 Institutional Programme FUNDING HEALTH INNOVATION 159
Performance Information 28 Grants Innovation and
STATEMENT OF RESPONSIBILITY Product Development 159
AND CONFIRMATION OUTCOMES, OUTPUTS, OUTPUT
OF ACCURACY FOR THE INDICATORS, TARGETS AND GIPD Programme and
ANNUAL REPORT 15 ACTUAL ACHIEVEMENTS 32 Strategic Project Updates 159
Supporting a Vaccine
STRATEGIC OVERVIEW 16 RESEARCH PROGRAMMES Development Ecosystem 171
Our vision 17 AND UNITS WITHIN THE SAMRC 38
DIVISION OF RESEARCH
Our mission 17 SAMRC STRATEGIC CAPACITY DEVELOPMENT 182
Our values 17 RESEARCH PROGRAMMES 40
Overview 182
LEGISLATIVE AND OTHER PROGRAMME 1: HEALTH
MANDATES 18 PROMOTION AND
DISEASE PREVENTION 40
ORGANISATIONAL STRUCTURE 19
PROGRAMME 2: MATERNAL,
A BROADER APPROACH CHILD AND WOMENS’S HEALTH 70
TO TRANSFORMATION
AT THE SAMRC 20

PARTNERSHIPS WITH
OTHER COUNTRIES 23